Navigation Links
BioSpecifics Technologies Corp. to Host Conference Call to Report Third Quarter 2011 Financial Results on November 8, 2011
Date:11/1/2011

LYNBROOK, N.Y., Nov. 1, 2011 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® in the U.S. and XIAPEX® in Europe and Eurasia, announced today that it will host a conference call and live audio webcast at 8:30 a.m. EST on Tuesday, November 8, 2011 to report its third quarter 2011 financial results and provide a corporate update.

In order to participate in the conference call, please dial 800-860-2442 (domestic) or 412-858-4600 (international). The live webcast can be accessed under "Calendar of Events" in the Investor Relations section of the Company's website at www.biospecifics.com, or you may use the link: http://www.videonewswire.com/event.asp?id=83154.

A replay of the call will be available one hour after the end of the conference on November 8, 2011 until 9:00 a.m. EST on November 18, 2011. To access the replay, please dial 877-344-7529 (domestic) or 412-317-0088 (international) and reference the access code 10005920. The archived webcast will be available for 90 days in the Investor Relations section of BioSpecifics' website at www.biospecifics.com.

About BioSpecifics Technologies Corp.

BioSpecifics Technologies Corp. is a biopharmaceutical company that has developed injectable collagenase for twelve clinical indications. Its partner Auxilium Pharmaceuticals, Inc. markets XIAFLEX® in the U.S. for the treatment of Dupuytren's contracture in adults with palpable cord in the palm and is also developing XIAFLEX for the treatment of Peyronie's disease which is currently in Phase 3 pivotal clinical trials, frozen shoulder (Adhesive Capsulitis) and cellulite. Pfizer, Inc. is
'/>"/>

SOURCE BioSpecifics Technologies Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. BioSpecifics Technologies Corp. Announces Data Presentations at Upcoming XVI Annual Federation of the European Societies for Surgery of the Hand Meeting
2. BioSpecifics Technologies Corp. Reports First Quarter 2011 Financial Results
3. BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2010 Financial Results
4. BioSpecifics Technologies Corp. to Host Conference Call to Report Fourth Quarter and Full Year 2010 Financial Results on March 11, 2011
5. BioSpecifics Technologies Corp. to Present at Cowen and Company 31st Annual Health Care Conference
6. BioSpecifics Announces Positive Results From Clinical Trial in Canine Lipomas
7. BioSpecifics Technologies Corp. to Present at UBS Global Life Sciences Conference
8. BioSpecifics Technologies Corp. to Present at Rodman & Renshaw 12th Annual Healthcare Conference
9. Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results
10. BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results
11. BioSpecifics Technologies Corp. to Host Conference Call to Report Third Quarter 2009 Financial Results on November 5, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2015)... February 28, 2015 Increasing its efforts to ... launches its first three episodes of The GMO TRUTH podcast ... this month, as it continues its mission to discover the ... project's first phase, to “uncover the truth about the GMOs ... , The GMO Truth Podcast is an expansion of the ...
(Date:2/27/2015)... Immunovaccine Inc. (“Immunovaccine” or the “Company”) ... press release disseminated this morning by PR Web, and ... press release states that Immunovaccine has entered into a ... release did not originate from Immunovaccine and there is ... release. Please note that all official statements by ...
(Date:2/27/2015)... Md. and SUMMERLAND, British Columbia ... (NYSE: XON ), a leader in ... agreement to acquire  Okanagan Specialty Fruits (OSF), the ... apple , the world,s first non-browning apple. Through the ... yielding fruit that is more appetizing and convenient for ...
(Date:2/27/2015)... 2015  Pharmacyclics, Inc. (NASDAQ: PCYC ... its newly developed Bruton,s tyrosine kinase (BTK) inhibitor ... The results of these preclinical evaluations have been ... The feedback received from the Agency is supportive ... Additional preclinical work is required to begin a ...
Breaking Biology Technology:The Walk a Mile Project Launches “GMO Truth” Podcast 2Immunovaccine Disclaims Hoax Press Release 2Intrexon to Acquire Okanagan Specialty Fruits 2Intrexon to Acquire Okanagan Specialty Fruits 3Intrexon to Acquire Okanagan Specialty Fruits 4Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 3
... in the U.S. and ... in Key Global Markets, ... JERUSALEM and MONTVALE, N.J., July 18 Teva,Pharmaceutical Industries Ltd. ... announced today that they have signed a definitive,agreement under which Teva ...
... Md., July 18 Northwest,Biotherapeutics, Inc. (AIM: NWBS ... NWBT"), today announced that Dr. Alton L. Boynton, ... presentation updating,the Company,s progress in the development of ... "Next Generation Vaccines" conference. The,conference will be held ...
... -- The Defense Advanced Research Projects Agency (DARPA) has ... of Harvard University researchers to study surface enhanced Raman ... three-year effort. , If all phases of the development ... of up to $2.9 million in funding. , Ken ...
Cached Biology Technology:Teva to Acquire Barr 2Teva to Acquire Barr 3Teva to Acquire Barr 4Teva to Acquire Barr 5Teva to Acquire Barr 6Teva to Acquire Barr 7Teva to Acquire Barr 8Northwest Biotherapeutics to Present at Next Generation Vaccine Conference 2DARPA awards research team $1.2M grant to study surface enhanced Raman scattering 2
(Date:2/5/2015)... TRIANGLE PARK, North Carolina , 5. ... sein 35. Jahr als spezialisiertes Logistikunternehmen und ... Position als einzige klinische Logistikfirma (Clinical Logistics ... Die Kernbotschaft der neuen Kampagne lautet ... und Lieferungen. Foto: http://photos.prnewswire.com/prnh/20150205/173753 ...
(Date:2/5/2015)... NXT-ID, Inc. (NASDAQ: NXTD and ... focused on the growing mobile commerce market, announces the ... as part of its 2015 marketing and branding initiatives ... new consumer website for Wocketwallet.com earlier this month. ... said, "Our new corporate website naturally showcases our premiere ...
(Date:2/5/2015)... OXFORD, Conn. , Jan. 28, 2015 ... ("NXT-ID" or the "Company"), a biometric authentication company focused ... present at the upcoming RedChip Global Online CEO Conference ... Gino Pereira , CEO of ... discussing its lead product, the Wocket smart wallet and ...
Breaking Biology News(10 mins):Marken startet Kampagne mit Patienten im Mittelpunkt 2Marken startet Kampagne mit Patienten im Mittelpunkt 3NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3
... Bethesda, MD FASEB MARC (Minority Access to Research ... the 2010 Societ Italiana di Patologia (SIP) XXX National ... These awards are meant to promote the entry of ... of the basic science community and to encourage the ...
... PITTSBURGH, Sept. 20 A structural molecule and the cellular ... and could provide new ways of treating the lung infection, ... to scientists at the University of Pittsburgh and the University ... Medicine . Despite decades of research, there has ...
... Inc. (Nasdaq: AWRE ), a global provider ... will introduce and demonstrate several new biometrics software products ... Conference and Technology Expo. The event takes place in ... to be demonstrated include Forensic Workbench, FormScanner, and BioSP™ ...
Cached Biology News:Pitt/Iowa team finds cellular structural molecule can be toxic: Makes pneumonia worse 2Aware to Introduce Several New Software Products at the Biometrics Consortium Conference 2Aware to Introduce Several New Software Products at the Biometrics Consortium Conference 3Aware to Introduce Several New Software Products at the Biometrics Consortium Conference 4
...
Mouse monoclonal [2G1] to Vancomycin ( Abpromise for all tested applications)....
Rab1A...
... polyclonal to LYZL6 ( Abpromise ... Antigen: Synthetic peptide: DWLCL ... , corresponding to amino acids 46-100 ... Entrez Gene ID: 57151 ...
Biology Products: